These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22510500)

  • 1. Hepatitis C, porphyria cutanea tarda and liver iron: an update.
    Ryan Caballes F; Sendi H; Bonkovsky HL
    Liver Int; 2012 Jul; 32(6):880-93. PubMed ID: 22510500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload in porphyria cutanea tarda.
    Sampietro M; Fiorelli G; Fargion S
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hepatitis C virus and porphyria cutanea tarda.
    To-Figueras J
    Mol Genet Metab; 2019 Nov; 128(3):282-287. PubMed ID: 31097365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for porphyria cutanea tarda -the iron/HFE connection.
    Bonkovsky HL;
    Liver Int; 2013 Jan; 33(1):162. PubMed ID: 23121614
    [No Abstract]   [Full Text] [Related]  

  • 5. Porphyria cutanea tarda in the Basque Country: significance of HFE gene mutations and of external factors.
    Castiella A; Zapata E; Otazua P; Zubiaurre L
    Liver Int; 2012 Nov; 32(10):1597. PubMed ID: 22680055
    [No Abstract]   [Full Text] [Related]  

  • 6. Porphyria cutanea tarda.
    Bleasel NR; Varigos GA
    Australas J Dermatol; 2000 Nov; 41(4):197-206; quiz 207-8. PubMed ID: 11105361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda].
    Székely E; Tasnádi G; Szentmihályi K; Almási A; Bor M; Fehér J; Blázovics A
    Orv Hetil; 2007 Jun; 148(23):1095-100. PubMed ID: 17545118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Porphyria cutanea tarda: the benefit of additional diagnostics].
    Vossen AR; Boesten LS; Siersema PD; Nellen RG
    Ned Tijdschr Geneeskd; 2016; 160():A9166. PubMed ID: 26840933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of porphyria cutanea tarda.
    Köstler E; Wollina U
    Expert Opin Pharmacother; 2005 Mar; 6(3):377-83. PubMed ID: 15794729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of porphyria cutanea tarda.
    Sarkany RP
    Clin Exp Dermatol; 2001 May; 26(3):225-32. PubMed ID: 11422163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
    Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
    Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda.
    Fritsch C; Lang K; von Schmiedeberg S; Bolsen K; Merk H; Lehmann P; Ruzicka T
    Skin Pharmacol Appl Skin Physiol; 1998; 11(6):321-35. PubMed ID: 10343203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda: Recent update.
    Singal AK
    Mol Genet Metab; 2019 Nov; 128(3):271-281. PubMed ID: 30683557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience in management of porphyria cutanea tarda in a tertiary referral Brazilian hospital from 2002 to 2017.
    Cabezas Arteaga JE; Vieira FMJ; Silva Dos Reis VM
    Int J Dermatol; 2019 Aug; 58(8):925-932. PubMed ID: 30773624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyria cutanea tarda--when skin meets liver.
    Frank J; Poblete-Gutiérrez P
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):735-45. PubMed ID: 20955974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
    Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
    Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.